Seth Lederman - Feb 27, 2024 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role: Chief Executive Officer, Director
Signature: /s/ Seth Lederman
Stock symbol: TNXP
Transactions as of: Feb 27, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/29/2024, 05:08 PM
Previous filing: Feb 24, 2023
Next filing: Feb 27, 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNXP	Stock Option	Award	$0	+235K		$0.00	235K	Feb 27, 2024	Common Stock	235K	$0.37	Direct	F1, F2
transaction	TNXP	Stock Option	Award	$0	+1.9M		$0.00	1.9M	Feb 27, 2024	Common Stock	1.9M	$0.46	Direct	F1, F2
transaction	TNXP	Stock Option	Award	$0	+1.31M		$0.00	1.31M	Feb 27, 2024	Common Stock	1.31M	$0.04	Direct	F2

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F2	The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.